Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
PHOX2A (formerly ARIX) has been proposed as the gene underlying the autosomal recessive form of congenital fibrosis of the extraocular muscles (CFEOM2). Comprehensive sequencing in a sporadic 9-month-old patient with classic CFEOM features revealed no pathogenic PHOX2A variants (PMID:12208268). Subsequent analysis of 11 CFEOM1 pedigrees (nine linked to FEOM1 and two to FEOM3) and five sporadic classic CFEOM cases likewise failed to identify ARIX/PHOX2A mutations (PMID:11882252, PMID:15747768). Screening of 12 CFEOM3 families and 10 sporadic CFEOM3 probands also detected no PHOX2A variants, despite uncovering KIF21A mutations in some pedigrees (PMID:15223798).
The absence of pathogenic PHOX2A variants across diverse familial and sporadic CFEOM1–3 cohorts argues against a major role for PHOX2A in classic CFEOM presentations. These negative findings underscore significant genetic heterogeneity and point to unidentified loci underlying recessive CFEOM2 and related phenotypes. Currently, clinical testing of PHOX2A for CFEOM lacks support until bona fide pathogenic variants are discovered.
Gene–Disease AssociationDisputedNo pathogenic PHOX2A variants identified in 1 sporadic case and 33 pedigrees/cases across four cohorts ([PMID:12208268], [PMID:11882252], [PMID:15747768], [PMID:15223798]). Genetic EvidenceNoneZero pathogenic PHOX2A variants detected across >33 probands in multiple CFEOM1, CFEOM2, and CFEOM3 cohorts. Functional EvidenceNoneNo functional studies of PHOX2A in CFEOM phenotypes reported. |